Natera (NTRA)
Applies personalized molecular testing across reproductive health, oncology, and organ health.
$387.33
vs last close+16.68 (+4.50%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
in 44 days
EPS estimate
−$0.22
Revenue estimate
$707.9M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported−$0.41−$0.50−$0.74−$0.64$0.35−$0.56−$0.47Pending
Estimate−$0.38−$0.64−$0.62−$0.39−$0.51−$0.54−$0.49−$0.22
Surprise−7.6%+21.9%−20.2%−65.9%+168.4%−3.3%+4.8%—
RevenueReportedEstimate
Feb '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$476.1M$501.8M$546.6M$592.2M$665.5M$696.6M$752.8MPending
Estimate$435.6M$446.2M$476.3M$513.5M$604.0M$617.1M$661.2M$707.9M
Surprise+9.3%+12.5%+14.8%+15.3%+10.2%+12.9%+13.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.52 | — | — |
| Sep 2028 | $0.43 | — | — |
| Jun 2028 | $0.37 | — | — |
| Mar 2028 | $0.34 | — | — |
| Dec 2027 | $0.05 | — | — |
| Sep 2027 | −$0.06 | — | — |
| Jun 2027 | −$0.16 | — | — |
| Mar 2027 | −$0.20 | — | — |
| Dec 2026 | −$0.05 | — | — |
| Nov 2026 | −$0.22 | — | — |
| Aug 2026 | −$0.49 | −$0.47 | +4.8% |
| May 2026 | −$0.54 | −$0.56 | −3.3% |
| Feb 2026 | −$0.51 | $0.35 | +168.4% |
| Nov 2025 | −$0.39 | −$0.64 | −65.9% |
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.52 | — | — | $1.08B | — | — | — |
| Sep 2028 | $0.43 | — | — | $1.02B | — | — | — |
| Jun 2028 | $0.37 | — | — | $1.00B | — | — | — |
| Mar 2028 | $0.34 | — | — | $945.9M | — | — | — |
| Dec 2027 | $0.05 | — | — | $916.9M | — | — | — |
| Sep 2027 | −$0.06 | — | — | $869.1M | — | — | — |
| Jun 2027 | −$0.16 | — | — | $855.2M | — | — | — |
| Mar 2027 | −$0.20 | — | — | $809.4M | — | — | — |
| Dec 2026 | −$0.05 | — | — | $748.2M | — | — | — |
| Nov 5, 2026 | −$0.22 | — | — | $707.9M | — | — | — |
| Aug 6, 2026 | −$0.49 | −$0.47 | +4.8% | $661.2M | $752.8M | +13.8% | +21.4% |
| May 7, 2026 | −$0.54 | −$0.56 | −3.3% | $617.1M | $696.6M | +12.9% | −11.6% |
| Feb 26, 2026 | −$0.51 | $0.35 | +168.4% | $604.0M | $665.5M | +10.2% | −3.7% |
| Nov 6, 2025 | −$0.39 | −$0.64 | −65.9% | $513.5M | $592.2M | +15.3% | +0.6% |
| Aug 7, 2025 | |||||||
| May 8, 2025 | |||||||
| Feb 27, 2025 | |||||||
| Nov 12, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 3, 2023 | |||||||
| May 9, 2023 | |||||||
| Feb 28, 2023 | |||||||
| Nov 8, 2022 | |||||||
| Aug 4, 2022 | |||||||
| May 5, 2022 | |||||||
| Feb 24, 2022 | |||||||
| Nov 4, 2021 | |||||||
| Aug 5, 2021 | |||||||
| May 6, 2021 | |||||||
| Feb 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Feb 26, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 7, 2019 | |||||||
| May 9, 2019 | |||||||
| Mar 12, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 8, 2018 | |||||||
| May 8, 2018 | |||||||
| Mar 13, 2018 | |||||||
| Nov 8, 2017 | |||||||
| Aug 8, 2017 | |||||||
| May 9, 2017 | |||||||
| Mar 7, 2017 | |||||||
| Nov 9, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 10, 2016 | |||||||
| Mar 8, 2016 | |||||||
| Nov 12, 2015 | |||||||
| Aug 12, 2015 |